FRANKFURT--(BUSINESS WIRE)--Merz Pharma Group today announced the commencement of its tender offer for all outstanding shares of common stock of BioForm Medical, Inc. (Nasdaq: BFRM) for $5.45 per share, net to the seller in cash, without interest and less any required withholding tax. The tender offer is being made by Vine Acquisition Corp., an indirect wholly-owned subsidiary of Merz GmbH & Co. KGaA (“Merz”), in connection with the Agreement and Plan of Merger among Merz, Vine Acquisition Corp. and BioForm Medical, announced on January 4, 2010, and pursuant to an Offer to Purchase dated January 15, 2010.
